Belpointe Asset Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-632
Closed -$121K 3024
2023
Q1
$121K Buy
632
+45
+8% +$8.7K 0.01% 1201
2022
Q4
$108K Sell
587
-211
-26% -$37.1K 0.01% 1194
2022
Q3
$132K Buy
798
+295
+59% +$60K 0.01% 1019
2022
Q2
$103K Buy
503
+23
+5% +$5.19K 0.01% 1102
2022
Q1
$116K Sell
480
-6
-1% -$1.39K 0.01% 1150
2021
Q4
$119K Buy
+486
New +$111K 0.01% 1120

Other funds holding STE

Belpointe Asset Management's STE Position: Q2 2023 in Review

Belpointe Asset Management sold out of Steris (STE) in Q2 2023, closing a stake of 632 shares — an estimated $121K sold.

Belpointe Asset Management first reported a position in STE in Q4 2021 and held it in 6 quarters. The position peaked at $132K in Q3 2022. 657 funds tracked by Wall St. Rank hold STE as of Q2 2023.

  • Belpointe Asset Management reported no remaining Steris position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 632 Steris shares in Q2 2023, an estimated $121K.
  • Belpointe Asset Management first reported a position in Steris in Q4 2021 and held it in 6 quarters.
  • Belpointe Asset Management's Steris position peaked at $132K in Q3 2022.
  • 657 funds tracked by Wall St. Rank held Steris as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.